Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. SS Innovations International's Total Liabilities for the quarter that ended in Mar. 2026 was $36.02 Mil. SS Innovations International's Total Assets for the quarter that ended in Mar. 2026 was $90.55 Mil.
Therefore, SS Innovations International's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2026 was 0.40.
SS Innovations International (NAS:SSII) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
SS Innovations International Liabilities-to-Assets Related Terms
SS Innovations International Liabilities-to-Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SS Innovations International Liabilities-to-Assets Chart
SSII vs BVS, TCMD, BBNX: Liabilities-to-Assets Comparison
For the Medical Devices subindustry, SS Innovations International's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SS Innovations International Liabilities-to-Assets vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where SS Innovations International's Liabilities-to-Assets falls into.
SS Innovations International Liabilities-to-Assets Calculation
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
SS Innovations International's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SS Innovations International (SSII) has a Liabilities-to-Assets of 0.40 as of Mar. 2026. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on SS Innovations International and its competitors.
Is SS Innovations International's Liabilities-to-Assets too high?
SS Innovations International's current Liabilities-to-Assets is 0.40. Overall, SS Innovations International has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SS Innovations International's Liabilities-to-Assets compare to BVS and TCMD?
SS Innovations International's Liabilities-to-Assets of 0.40 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Medical Devices & Instruments company?
A good Liabilities-to-Assets depends on the Medical Devices & Instruments industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on SS Innovations International and its competitors. SS Innovations International's current Liabilities-to-Assets is 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SS Innovations International stock overvalued right now?
Based on GuruFocus' analysis, SS Innovations International (SSII) is currently considered Possible Value Trap. The stock's GF Value™ is $18.71, compared to a current price of $3.60 — trading 80.8% below its estimated fair value. The current Liabilities-to-Assets is 0.40. SS Innovations International's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For SS Innovations International (SSII), the current Liabilities-to-Assets is 0.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SS Innovations International (SSII) Overvalued in 2026?
Based on GuruFocus' analysis, SS Innovations International stock appears to be undervalued.
The current stock price of $3.60 is trading 80.8% below its estimated GF Value™ of $18.71.
GuruFocus considers SS Innovations International to be Possible Value Trap.
Key valuation signals for SSII:
Liabilities-to-Assets: 0.40
GF Value™: $18.71 vs. price of $3.60 (80.8% below fair value)
No single metric tells the full story. See the SSII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
41GF Score
Get the complete analysis for SSII
Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSII has been successfully added to your 
